Tuesday, 27 April 2021, 6:03 am Starting Its Industrial Investment In Biotech Companies, China Medical System (0867.HK) Has Accelerated Its Flywheel Of Innovation HONG KONG, Apr 26, 2021 - (ACN Newswire) - China Medical System Holdings Limited (0867.HK) ("CMS" or the "Company") has been active in the market this year. From the acquisition of Luqa to enter the medical aesthetic market early this year, the Company has attracted the attention of the market. Recently, it has announced the series of agreement signed with Trinomab Biotech Co., Ltd. ("Trinomab"). CMS will make equity investment in Trinomab, and establish a joint venture (the "Joint Venture") with Trinomab, contributed with cash and related products